A rough colored sketch of a cavedweller na'vi, with dusty skin, grey hair and pale eyes. He wears a loincloth and leans against a spear.

Small warm-up of Ta'mok, a member of a cavedwelling Na'vi clan that I haven't named yet. They've evolved to have no connection to Eywa, and so do not have a fully functioning kuru. They live in near total darkness.

[ #avatarsky #na'vioc #fanclan #avtr ]

🚨 Institutions #optionsvolume surge detected! Weekly Top Momentum Activity from 🔥 INSIDERFINANCE.

🚨 Institutions #optionsvolume surge detected!

Weekly Top Momentum Activity from 🔥 INSIDERFINANCE.COM 🔥
1. #PEGA 123.4x
2. #MNDY 18.9x
3. #MLCO 16.5x
4. #AVTR 14.4x
5. #IBRX 14.3x

#OptionFlow #OptionsTrading #Trading

Avantor, Inc. Faces Class Action Lawsuit Over Securities Violations Avantor, Inc. is facing a class action lawsuit due to alleged violations of securities laws. The case could impact shareholders who purchased AVTR stocks during a specified period.

Avantor, Inc. Faces Class Action Lawsuit Over Securities Violations #United_States #Los_Angeles #DJS_Law_Group #Avantor_Inc #AVTR

Stock news image

$AVTR: director MEHRA SANJEEV K purchased 350,000 shares worth $3.9M

www.sec.gov/Archives/edgar/data/1722...

Track $AVTR insider activity: https://stockoscope.com/stock/avtr/stake

#AVTR #AvantorInc #Healthcare

Opportunities Emerge for Avantor, Inc. Shareholders Facing Losses in Securities Fraud Lawsuit Shareholders of Avantor, Inc. have gained a chance to lead a securities fraud class action lawsuit following financial losses. Key details inside.

Opportunities Emerge for Avantor, Inc. Shareholders Facing Losses in Securities Fraud Lawsuit #United_States #Los_Angeles #Securities_Fraud #Avantor #AVTR

Gross Law Firm Initiates Class Action for Avantor, Inc. (AVTR) Shareholders Amid Concerns The Gross Law Firm has announced the filing of a securities class action for Avantor, Inc. shareholders who bought AVTR shares. Key information about the allegations and next steps are provided.

Gross Law Firm Initiates Class Action for Avantor, Inc. (AVTR) Shareholders Amid Concerns #United_States #New_York #Gross_Law_Firm #Avantor_Inc #AVTR

Avantor, Inc. (AVTR) Investors: December 29, 2025 Filing Deadline in Securities Class Action – Contact Lieff Cabraser #stocknews #AVTR

Learn more here: www.lieffcabraser.com/2025/11/avan...

Class Action Lawsuit Filed Against Avantor, Inc.: Key Details for Investors Investors in Avantor, Inc. should be alert as a class action lawsuit has been filed, seeking recovery for alleged securities fraud. The deadline to participate is December 29, 2025.

Class Action Lawsuit Filed Against Avantor, Inc.: Key Details for Investors #USA #New_York #Class_Action #Levi_&_Korsinsky #AVTR

Avantor Inc. Class Action Lawsuit: Important Information for Stockholders Robbins LLP urges Avantor, Inc. stockholders who faced significant losses to join the class action lawsuit filed against the company for misleading investors about competition effects.

Avantor Inc. Class Action Lawsuit: Important Information for Stockholders #USA #San_Diego #Robbins_LLP #Inc. #Avantor #AVTR

Avantor® Unveils Next-Generation Sterile Sampling Platform and PUPSIT Assemblies Avantor (NYSE: AVTR) on October 30, 2025 launched a next-generation sterile sampling platform and pre-engineered PUPSIT assemblies to streamline bioprocessing qualification and in-process decision-making.The suite includes NBSS (needle-based), NFSS (needle-free), EVSS (exact-volume sampling) and OmniTop, offering modular multi-sample configurations, closed-path designs, standardized bills of materials, and supplier-agnostic PUPSIT assemblies that integrate with common filtration trains to reduce line breaks, operator intervention, and setup variability.Avantor says the products support single-use and hybrid facilities across clinical to commercial scale, aiming to improve product protection, operational safety, and speed of decisions.

#AVTR Avantor® Unveils Next-Generation Sterile Sampling Platform and PUPSIT Assemblies

www.stocktitan.net/news/AVTR/avantor-unveil...

Avantor® Reports Third Quarter 2025 Results Net sales of $1.62 billion, decrease of 5% Net loss of $712 million and diluted GAAP loss per share of $1.04, including a non-cash goodwill impairment charge of $785 million Adjusted EBITDA of $268 million; adjusted EPS of $0.22 Operating cash flow of $207 million; free cash flow of $172 million Company announces $500 million share repurchase authorization,...

#AVTR Avantor® Reports Third Quarter 2025 Results

www.stocktitan.net/news/AVTR/avantor-report...

Avantor® Announces Partnership with p-Chip Corporation to Develop Solutions for Digital Traceability of Smart Consumables New product line will enable secure chain-of-identity, enhanced traceability, and digital process control in pharmaceutical and clinical workflows– supporting the growing demand for individualized therapies. RADNOR, Pa. and CHICAGO, Oct. 23, 2025/ PRNewswire/-- Avantor, Inc., a leading global provider of mission-critical products and services to customers in...

#AVTR Avantor® Announces Partnership with p-Chip Corporation to Develop Solutions for Digital Traceability of Smart Consumables

www.stocktitan.net/news/AVTR/avantor-announ...

Avantor® and BlueWhale Bio Partner to Accelerate CAR-T Manufacturing with Breakthrough Cell Activation and Expansion Technology RADNOR, Pa. and PHILADELPHIA, Oct. 15, 2025/ PRNewswire/-- Avantor, Inc., a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies industries, today announced a strategic partnership with BlueWhale Bio, a commercial-stage company dedicated to transforming immune cell therapy...

#AVTR Avantor® and BlueWhale Bio Partner to Accelerate CAR-T Manufacturing with Breakthrough Cell Activation and Expansion Technology

www.stocktitan.net/news/AVTR/avantor-and-bl...

Avantor® Reiterates Shareholder Value Creation Focus Avantor (NYSE:AVTR), a global provider of life sciences and advanced technology products, has responded to Engine Capital's letter by reaffirming its commitment to shareholder value creation. The company highlighted several strategic initiatives, including the appointment of Emmanuel Ligner as CEO effective August 18, 2025, the implementation of a $400 million cost transformation program, and successful debt reduction of $1.5 billion over the past 18 months.The Board emphasized its focus on strengthening growth and profitability in Laboratory Solutions and Bioscience Production segments, while highlighting recent leadership changes and increased business transparency through resegmentation efforts.

#AVTR Avantor® Reiterates Shareholder Value Creation Focus

www.stocktitan.net/news/AVTR/avantor-reiter...

Avantor® Reports Second Quarter 2025 Results Avantor (NYSE:AVTR) reported mixed Q2 2025 financial results with net sales of $1.68 billion, showing a 1% decrease year-over-year, while organic revenue remained flat. The company posted net income of $64.7 million, down from $92.9 million in Q2 2024, with diluted EPS of $0.09 and adjusted EPS of $0.24.The Laboratory Solutions segment saw a 3% decline in net sales to $1.12 billion, while Bioscience Production grew 3% to $561.3 million. The company generated operating cash flow of $154.4 million and free cash flow of $125.4 million, maintaining an adjusted net leverage of 3.2x.Additionally, Avantor announced a significant leadership change, with Emmanuel Ligner appointed as the new President and CEO, effective August 18, 2025, replacing Michael Stubblefield.

#AVTR Avantor® Reports Second Quarter 2025 Results

www.stocktitan.net/news/AVTR/avantor-report...

A half-body color sketch of a na'vi oc named Malor, part of the Mangkwan. His head is half shaved while the other half is protected in a microloc style. Behind him is a blazing color of reds, oranges, and yellows of flames. His expression is contorted, his eyes glaring at his opponent off screen.

A sketch of Malor, a member of the Mangkwan. Small, violent, and as fast as greased devil spit. Don't turn your back on him.

#AvatarSky | #Sketch | #SimuAVTR | #Mangkwan | #OCSky | #AVTR | #Na'vi | #Na'viOC

A half-body colored sketch of Recombinant OC, Roan-Avery Maddox. It's roughly colored and on a painted white background. He has his arms folded over his chest, wearing a plain black tee and with a communication choker around his neck. His right arm is covered in floral tattoos that reach his neck. He smiles, looking at someone off screen.

I've never done art fight, so it felt appropriate to draw my boyfriends OC, Roan, who is good of heart, dumb of ass.

#AvatarSky | #ArtFight2025 | #Sketch | #ArtSky | #Avatar | #AVTR | #OCSky

The Disneyland Resort Is Trading 'Monsters Inc.' for 'Avatar' Disney already announced new attracts for 'Coco' and 'Avatar' but now we know where they're going, and what's leaving.

The Disneyland Resort Is Trading ‘Monsters Inc.’ for ‘Avatar’ Disney already announced new attracts for 'Coco' and 'Avatar' but now we know where they're going, and what's leaving.. @cosmicmeta.io #AVTR

https://u2m.io/QPdwRhTH

Insider Buying Week 05-30-25-Could Harvard University go Public? It was a generally positive month, marked by tariff moderations and largely favorable economic news regarding inflation. Trump, possibly feeling […]

Avantor serves biopharma, healthcare, education, and government sectors globally. Q1 revenues fell 5.9% but the stock may be oversold given current political headwinds.
Get the complete analysis: buff.ly/7kUy6K2
#InsiderBuying #AVTR #Biopharma #Contrarian #NotInvestmentAdvice

Insider Buying Week 05-09-25 Bargain Basement Week Finally, a busy week. I can’t extrapolate anything about the general market from these buys, but it’s clear that some […]

current challenges?
#InsiderBuying #AVTR #Biopharma #LifeSciences #NotInvestmentAdvice #FinancialAnalysis
For more insider buying analysis: www.theinsidersfund.com/2025/05/insi...

Insider Buying Week 05-02-25 Record Run for the Bulls Every bear market since 2001 has only ended with a plethora of insider buying.  I’m waiting, waiting, and waiting without […]

Properties, DOC."

#InsiderBuying #AVTR #Biotech #LifeSciences #TheInsidersFund #NotInvestmentAdvice
Stay ahead of the market - read all of Harvey's insider buying analysis at The Insiders Fund: bit.ly/4d3gIbT

Just In: ( NYSE: #AVTR ) Breaking Down the Key Takeaways from Avantor, Inc. (AVTR) Quarterly Report

Just In: ( NYSE: #AVTR ) Avantor Faces Steady Earnings, CEO Resigns, and Shifts Strategy

@thermofishersci.bsky.social #AVTR (VWR/Avantor) #BD #HenrySchein @cellsignalingsd.bsky.social #Bio-Rad @milliporesigma.bsky.social

Avantor's Massive Production Expansion: 4X Boost in Critical Biopharma Materials Avantor strengthens global supply chain with major European facility expansion, quadrupling hydration solutions capacity for biopharma manufacturing at Poland site.

#AVTR Avantor® Provides First Look at Recently Completed Hydration Expansion at DCAT Week 2025

www.stocktitan.net/news/AVTR/avantor-provid...

Could This UCLA Spin-off's Technology End Medical Device Infections? Major Partnership Announced Revolutionary surface treatment shows promise in preventing medical device infections and complications. Partnership expands access to FDA-cleared technology.

#AVTR Silq Technologies Corp. and NuSil Technology LLC Announce Collaboration Agreement to Drive Broad-based Adoption of Silq’s Novel Surface Treatment Technology

www.stocktitan.net/news/AVTR/silq-technolog...

HeatMaps - ORTEX

📢 This Morning’s Earnings Are In!

#NWL, #CGC, #PAA, #AVTR, #FLO, and more have reported. See how the market is reacting!

🔥 Get 50% off ORTEX and track earnings in real time.

app.ortex.com/earnings/hea...

#Earnings #StockMarket #Investing #Trading #ORTEX

Avantor® Reports Fourth Quarter and Full Year 2024 Results Avantor (AVTR) reported Q4 2024 results with net sales of $1.69 billion, showing a 2% decrease but 1% organic growth. Q4 net income reached $500.4 million with adjusted EBITDA of $307.7 million. Diluted GAAP EPS was $0.73 and adjusted EPS $0.27.For full year 2024, net sales were $6.78 billion, declining 3% with a 2% organic decrease. Annual net income was $711.5 million with adjusted EBITDA of $1,198.8 million. The company achieved operating cash flow of $840.8 million and free cash flow of $768.3 million.By segment, Laboratory Solutions reported Q4 sales of $1.13 billion, down 5%, while Bioscience Production showed Q4 sales of $560.8 million, up 4%. The company's bioprocessing platform grew high-single-digits, with management expressing confidence in achieving near-term and long-term financial goals.

#AVTR Avantor® Reports Fourth Quarter and Full Year 2024 Results

www.stocktitan.net/news/AVTR/avantor-report...

Strategic Distribution Deal: TriLink Brings Game-Changing mRNA Technology to EMEA Market TriLink partners with Avantor to enhance European access to nucleic acid products, streamlining ordering and reducing lead times for CleanCap® and mRNA solutions.

#MRVI #AVTR TriLink BioTechnologies® Partners with Avantor® to Expand Nucleic Acid Solutions in Europe

www.stocktitan.net/news/MRVI/tri-link-bio-t...

N-L8 - #TD The Toronto-Dominion Bank
N-L9 - #AVTR Avantor
N-L10 - #MOG.B Moog B
N-L11 - #KMX CarMax
N-L12 - #VNT Vontier Corporation
N-L13 - #SUZ Suzano
N-L14 - #HEI.A HEICO A
N-L15 - #MGA Magna International
N-L16 - #GPN Global Payments
N-L17 - #VVV Valvoline
N-L18 - #NTRS Northern Trust